Yesterday, Tuesday, March 25, 2014, Integra LifeSciences
launched their new skin and wound product: Integra Wound Matrix (Thin). It has received 510K clearance from the USFDA
and Integra is anticipating a full market release next month after being featured
at the American Burn Association Annual Meeting which taking place in Boston
this week. This product expands the
opportunities for treatments from their original Integra Wound Matrix and can
now be useful on more “complex anatomical sites” than the original
version. The treatments of the product
includes, but is not limited to: second degree burns, various types of wounds, and
various types of ulcers. It can be
purchased in a number of different sizes, and has a shelf-life of one
year. Integra closed today at $45.26 representing
a 12% upside from our original buy price of $40.41.
No comments:
Post a Comment